APATINIB for Hepatic cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 18 adverse event reports in the FDA FAERS database where APATINIB was used for Hepatic cancer.
Most Reported Side Effects for APATINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Myelosuppression | 30 | 19.4% | 2 | 9 |
| Palmar-plantar erythrodysaesthesia syndrome | 28 | 18.1% | 5 | 1 |
| Proteinuria | 23 | 14.8% | 3 | 0 |
| Fatigue | 22 | 14.2% | 4 | 1 |
| Rash | 21 | 13.6% | 3 | 2 |
| Hypertension | 20 | 12.9% | 3 | 1 |
| Anaemia | 19 | 12.3% | 5 | 0 |
| Diarrhoea | 17 | 11.0% | 2 | 2 |
| Decreased appetite | 15 | 9.7% | 4 | 1 |
| Leukopenia | 15 | 9.7% | 1 | 0 |
| Disease progression | 14 | 9.0% | 4 | 0 |
| Nausea | 13 | 8.4% | 3 | 1 |
| Thrombocytopenia | 13 | 8.4% | 2 | 1 |
| Platelet count decreased | 12 | 7.7% | 1 | 4 |
| Pyrexia | 11 | 7.1% | 1 | 1 |
Other Indications for APATINIB
Gastric cancer (12)
Non-small cell lung cancer (11)
Breast cancer (7)
Hepatocellular carcinoma (6)
Adenocarcinoma gastric (5)
Breast cancer metastatic (5)
Metastases to central nervous system (5)
Serous cystadenocarcinoma ovary (5)
Other Drugs Used for Hepatic cancer
SORAFENIB (1,167)
LENVATINIB (1,017)
BEVACIZUMAB (532)
CABOZANTINIB S-MALATE (508)
ATEZOLIZUMAB (459)
TISLELIZUMAB (315)
CAPECITABINE (267)
NIVOLUMAB (262)
REGORAFENIB (252)
OXALIPLATIN (188)